Virus entry is thought to involve binding a unique receptor for cell attachment and cytosolic entry. For SARS-CoV-2 underlying the COVID-19 pandemic, angiotensin- converting enzyme 2 (ACE2) is widely ...
Opinion
A Future Beyond Animal Testing: Why ORIVA Matters and How Computational Models Bridge the Gap
Animal testing is costly, slow, and poorly predictive. ORIVA offers a human-relevant alternative with the potential to change that.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback